Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 22.50 is in line with its 5-year average of 24.07, around the middle of its 5-year range (18.23–25.81).
11.75% below its 12-month average of 25.49.
Reported quarterly EPS; no daily interpolation.
EPS growth vs the same quarter one year earlier, last 40 quarters.
EARNINGS PER SHARE (EPS)
22.50
EARNINGS PER SHARE (EPS) AVG TTM
25.49
EARNINGS PER SHARE (EPS) AVG 3Y
25.23
EARNINGS PER SHARE (EPS) AVG 5Y
24.07
EARNINGS PER SHARE (EPS) AVG 10Y
19.23
EARNINGS PER SHARE (EPS) AVG 15Y
15.84
EARNINGS PER SHARE (EPS) AVG 20Y
13.47
CURRENT VS TTM AVG
-11.75%
CURRENT VS 3Y AVG
-10.83%
CURRENT VS 5Y AVG
-6.52%
CURRENT VS 10Y AVG
+16.98%
CURRENT VS 15Y AVG
+42.03%
CURRENT VS 20Y AVG
+67.07%
Elevance Health Inc.
Market Cap
$87.17B
Earnings Per Share (EPS)
22.50
TTM Avg
25.49
3Y Avg
25.23
5Y Avg
24.07
Market Cap
$87.04B
Earnings Per Share (EPS)
29.87
TTM Avg
25.45
3Y Avg
22.39
5Y Avg
20.36
Market Cap
$83.48B
Earnings Per Share (EPS)
40.43
TTM Avg
41.98
3Y Avg
40.38
5Y Avg
45.10
Market Cap
$72.89B
Earnings Per Share (EPS)
24.16
TTM Avg
17.27
3Y Avg
18.45
5Y Avg
18.81
Market Cap
$104.10B
Earnings Per Share (EPS)
37.37
TTM Avg
32.20
3Y Avg
28.04
5Y Avg
15.41
Market Cap
$105.97B
Earnings Per Share (EPS)
9.65
TTM Avg
8.18
3Y Avg
7.73
5Y Avg
6.75
Market Cap
$66.86B
Earnings Per Share (EPS)
2.46
TTM Avg
1.61
3Y Avg
1.19
5Y Avg
0.89
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Elevance Health Inc. (ELV) | $87.17B | 22.50 | 25.49 | 25.23 | 24.07 |
| HCA Healthcare, Inc. (HCA)vs › | $87.04B | 29.87 | 25.45 | 22.39 | 20.36 |
| Regeneron Pharmaceuticals, Inc. (REGN)vs › | $83.48B | 40.43 | 41.98 | 40.38 | 45.10 |
| GSK plc (GSK)vs › | $97.25B | 3.16 | 2.69 | 4.37 | 4.18 |
| Cigna Corporation (CI)vs › | $72.89B | 24.16 | 17.27 | 18.45 | 18.81 |
| Sanofi (SNY)vs › | $103.62B | 0.56 | 3.01 | 2.95 | 3.44 |
| McKesson Corporation (MCK)vs › | $104.10B | 37.37 | 32.20 | 28.04 | 15.41 |
| Stryker Corporation (SYK)vs › | $105.97B | 9.65 | 8.18 | 7.73 | 6.75 |
| Boston Scientific Corporation (BSX)vs › | $66.86B | 2.46 | 1.61 | 1.19 | 0.89 |
| Cencora, Inc. (COR)vs › | $63.17B | 13.46 | 7.81 | 8.10 | 3.88 |
Trailing EPS (TTM)
$22.50
Forward EPS (Est.)
$27.15
P/E Ratio
18.1
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | 25.18 |
| 2024-12-31 | 25.81 |
| 2023-12-31 | 25.38 |
| 2022-12-31 | 24.56 |
| 2021-12-31 | 25.25 |
| 2020-12-31 | 18.23 |
| 2019-12-31 | 18.81 |
| 2018-12-31 | 14.53 |
| 2017-12-31 | 14.70 |
| 2016-12-31 | 9.39 |
| 2015-12-31 | 9.73 |
| 2014-12-31 | 9.31 |
| 2013-12-31 | 8.89 |
| 2012-12-31 | 8.26 |
| 2011-12-31 | 7.80 |
| 2010-12-31 | 7.64 |
| 2009-12-31 | 9.96 |
| 2008-12-31 | 4.79 |
| 2007-12-31 | 5.64 |
| 2006-12-31 | 4.93 |
| 2005-12-31 | 4.03 |
| 2004-12-31 | 3.15 |
| 2003-12-31 | 2.80 |
| 2002-12-31 | 2.31 |
| 2001-12-31 | 1.66 |
| 2000-12-31 | 1.10 |
| 1999-12-31 | 0.22 |
| 1998-12-31 | 0.84 |
Reported annual fiscal-period values; no daily interpolation.
